C - Chemistry – Metallurgy – 07 – H
Patent
C - Chemistry, Metallurgy
07
H
C07H 21/00 (2006.01) A61K 31/70 (2006.01) C12N 15/11 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2235420
The present invention relates to the use of antisense oligonucleotides directed against specific nucleic acid sequences coding for receptors, alone or in combination, in order to inhibit the inflammatory reaction that is present in asthma, atopy or hypereosinophilia and to inhibit neoplastic cell proliferation. The antisense oligonucleotides of the present invention are used for treating and/or preventing asthma, allergy, hypereosinophilia, general inflammation or cancer. The oligonucleotides of the present invention are more specifically directed against nucleic acid sequences coding for a CCR3 receptor, a common subunit of IL-4 and IL-13 receptors, or a common subunit of IL-3, IL-5 and GM-CSF receptors.
Renzi Paolo
Swabey Ogilvy Renault
LandOfFree
Antisense oligonucleotides for treating or preventing atopic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antisense oligonucleotides for treating or preventing atopic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense oligonucleotides for treating or preventing atopic... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1486989